{
  "slug": "lavo-life-sciences",
  "name": "Lavo Life Sciences",
  "yc_id": 27201,
  "batch": "Winter 2023",
  "website": "https://www.lavo.ai/",
  "web_data": {
    "web_enrichment_version": "1.0.0",
    "enriched_at": "2025-10-17T01:19:26.299644",
    "website": "https://www.lavo.ai/",
    "website_status": {
      "reachable": true,
      "status_code": 200,
      "response_time_ms": 2820.28,
      "final_url": "https://lavo.ai/",
      "redirected": true,
      "checked_at": "2025-10-17T01:19:29.119936"
    },
    "ssl_security": {
      "disabled": true,
      "reason": "certificate_verification_failed"
    },
    "domain_info": {
      "domain": "lavo.ai",
      "registrar": "NAMECHEAP INC",
      "creation_date": "2022-05-28T16:53:37",
      "expiration_date": "2028-05-28T16:53:37",
      "domain_age_days": 1237,
      "domain_age_years": 3.4,
      "name_servers": [
        "dns1.registrar-servers.com",
        "dns2.registrar-servers.com"
      ]
    },
    "social_links": {
      "twitter": "https://x.com/lavoAI",
      "linkedin": "https://www.linkedin.com/company/lavo-life-sciences/",
      "github": null,
      "facebook": null,
      "instagram": null,
      "youtube": null
    },
    "security_headers": {
      "strict_transport_security": true,
      "content_security_policy": false,
      "x_frame_options": false,
      "x_content_type_options": false,
      "x_xss_protection": false,
      "referrer_policy": false,
      "security_score": 16,
      "server": "nginx"
    }
  },
  "enrichment_version": "1.0.0",
  "enriched_at": "2025-10-17T10:39:59.736680",
  "phase1_complete": true,
  "phase2_complete": false,
  "phase3_complete": false,
  "phase4_complete": false,
  "phase5_complete": false,
  "ai_insights": {
    "ai_insights_version": "1.0.0-claude",
    "model_used": "claude-sonnet-4-20250514",
    "enriched_at": "2025-10-17T10:52:48.440649",
    "market_analysis": {
      "market_size": "very large",
      "market_stage": "growing",
      "key_trends": [
        "AI-driven drug discovery acceleration",
        "Increased R&D efficiency demands due to rising costs",
        "Regulatory push for computational modeling validation"
      ]
    },
    "competitive_positioning": {
      "competitive_moat": "Proprietary AI algorithms for molecular simulation and specialized domain expertise in pharmaceutical formulation",
      "differentiation": "Focus specifically on drug formulation rather than broader drug discovery, targeting late-stage development bottlenecks",
      "competitive_advantages": [
        "Specialized formulation focus vs general drug discovery",
        "Potential for faster validation cycles"
      ],
      "competitive_vulnerabilities": [
        "Large tech companies entering space",
        "Established computational chemistry vendors"
      ]
    },
    "business_model": {
      "revenue_model": "SaaS",
      "scalability": "high",
      "capital_intensity": "medium"
    },
    "growth_assessment": {
      "growth_stage": "seed",
      "growth_indicators": [
        "Active status post-YC",
        "Established domain with 3.4-year-old website"
      ],
      "growth_bottlenecks": [
        "Long pharma sales cycles",
        "Need for extensive validation studies"
      ]
    },
    "risk_analysis": {
      "market_risk": "medium",
      "technology_risk": "high",
      "execution_risk": "high",
      "overall_risk_score": 7,
      "key_risks": [
        "Regulatory acceptance of AI predictions",
        "Competition from well-funded incumbents",
        "Long customer acquisition cycles in pharma"
      ]
    },
    "investment_thesis": {
      "strengths": [
        "Massive addressable market in pharma R&D",
        "Clear value proposition for cost/time savings",
        "YC backing and focused team"
      ],
      "concerns": [
        "Small team size for complex technical challenges",
        "High regulatory and validation requirements"
      ],
      "exit_potential": "acquisition",
      "comparable_companies": [
        "Schr\u00f6dinger",
        "Atomwise"
      ]
    },
    "recommendations": {
      "next_steps": [
        "Secure pilot partnerships with mid-tier pharma companies",
        "Build validation case studies and publish results"
      ],
      "expansion_opportunities": [
        "Adjacent markets like cosmetics or materials science",
        "Partnership with CROs for broader market access"
      ]
    },
    "tokens_used": {
      "input": 676,
      "output": 561,
      "total": 1237,
      "estimated_cost": 0.010443
    },
    "status": "success"
  },
  "phase8_complete": true
}